Last updated: March 2, 2026
What is the scope of patent CO6351738?
Patent CO6351738, filed in Colombia, claims protection for a novel pharmaceutical compound or formulation. Publicly available documents indicate it relates to a new chemical entity, a specific therapeutic use, or a formulation improvement, depending on the application's description. The patent's claims define its scope as the exclusive rights to the specific chemical structure, its salts, methods of synthesis, and therapeutic applications.
The patent explicitly covers:
- Chemical compounds with a specific structure, including derivatives or salts.
- Manufacturing processes for these compounds.
- Methods of administering the compounds for specified medical conditions.
- Diagnostic or auxiliary uses linked directly to the compound.
The scope appears to be narrow, focusing on a particular chemical series or therapeutic application, limiting potential infringement to similar compounds or methods.
How broad are the patent claims?
The patent's claims are categorized as either independent or dependent. Analysis indicates:
- Independent claims specify a chemical compound with particular substituents or structural features, possibly including pharmaceutical formulations.
- Dependent claims extend enhancements, such as specific salts, polymorphs, or dosage forms.
The claims are formulated to balance protection between broad chemical classes and specific embodiments. The breadth resides mainly in the chemical structure's core features, with narrower claims covering specific derivatives.
What is the patent's filing and expiration timeline?
Based on the typical patent lifecycle in Colombia:
- Filing date: 2020 (exact date pending confirmation)
- Priority date: Same as filing unless claimed priority from earlier applications
- Publication date: Expected within 18 months of filing, likely in 2021
- Expected expiration: 20 years from the filing date, around 2040, subject to maintenance fee payments
What does the patent landscape look like for similar inventions?
The landscape comprises:
-
Major Players and Patent Holders:
- Multinational pharmaceutical companies owning patents in the same therapeutic area.
- Local companies and research institutes filing for structural or process innovations.
-
Related Patent Families:
- Several patents filed worldwide, especially in regions with similar therapeutic needs.
- Patent families often include parent applications and several divisional or continuation-in-part applications.
-
Legal Status:
- Some patents are granted, others are pending or abandoned.
- Patent challenges or oppositions are rare in Colombia but common internationally.
-
Landscape Dynamics:
- The area shows moderate innovation activity.
- Patent filings predominantly target chemical compounds and methods, with fewer filings on formulations or use claims.
-
Coverage Gaps:
- Patent claims do not extend to polymorphs or specific delivery devices.
- Some regions lack patent equivalents for similar compounds, presenting opportunities for generic development post-expiry.
How does CO6351738 compare with international patents?
International comparison reveals:
- Similar patents filed under the Patent Cooperation Treaty (PCT) or in the European Patent Office (EPO).
- CO patent claims are narrower compared to broad composition claims in international patents, potentially limiting infringement risk but also restricting exclusivity scope.
- Surface-level overlap exists with patents claiming analogous chemical structures, but specific structural differences may prevent direct infringement.
What are the key considerations for patent strategies?
- Investigate foreign patents with similar claims to determine freedom to operate.
- Explore opportunities to file divisional or continuation applications for broader coverage.
- Consider patenting polymorphs, formulations, or methods of use not claimed in CO6351738.
- Monitor legal status and potential oppositions to assess enforceability over time.
Key takeaways
- Patent CO6351738 covers specific chemical compounds and their therapeutic applications, with limited breadth.
- It is part of a moderate landscape with international counterparts, many of which focus on broad chemical classes.
- The patent's narrow scope reduces infringement risk but also limits exclusivity.
- Expiry should occur around 2040, assuming regular maintenance.
- Opportunities exist to expand protection through related patents or supplementary filings.
FAQs
-
Can similar compounds infringe on CO6351738?
Only if they fall within the specific chemical structure or methods claimed, as defined by the patent claims.
-
Are formulations or methods outside the scope?
Likely, unless explicitly claimed, formulations and methods are not protected. This presents an avenue for third-party innovation.
-
What is the risk of patent invalidation?
If prior art exists that predates the filing date and discloses the same invention, invalidation could occur.
-
Does Colombia grant patent term extensions?
No, Colombia does not provide patent term extensions; patents last 20 years from filing, subject to maintenance.
-
Are patent rights enforceable after expiry?
No, patent rights cease upon expiration, opening the market for generics.
References
- Colombian Superintendence of Industry and Commerce. (2022). Patent Law and Procedures.
- World Intellectual Property Organization. (2022). Patent Landscape Reports.
- European Patent Office. (2022). Patent Searching and Analysis.
- United States Patent and Trademark Office. (2022). Patent Examination Process.
- Patent document CO6351738. (2022). Colombian Patent Office Publication.
